Angiodynamics Inc Quick Ratio (ANGO) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Angiodynamics Inc   (NASDAQ: ANGO)

Angiodynamics Inc 's Quick Ratio

ANGO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2026, Quick Ratio deteriorated to 0.57 below Angiodynamics Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 141 other companies have achieved higher Quick Ratio than Angiodynamics Inc in first quarter 2026. While Quick Ratio total ranking has improved so far during the Q1 2026 to 2553, from total ranking in the fourth quarter 2026 at 3112.

Explain Quick Ratio?
How much Cash & cash equivalents ANGO´s has?
What are ANGO´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ANGO/financial-strength
https://api.csimarket.com/api/v1/companies/ANGO/fundamentals
https://api.csimarket.com/api/v1/companies/ANGO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ANGO Quick Ratio (Aug 31 2026)
Q1
(May 31 2026)
Q4
(Feb 28 2026)
Q3
(Nov 30 2025)
Q2
(Aug 31 2025)
Q1
Y / Y Current Liabilities Change -12.58 %
Y / Y Cash & cash equivalent Change -12.35 %
Quick Ratio MRQ 0.57
ANGO's Total Ranking # 2553
Seq. Current Liabilities Change -20.11 %
Seq. Cash & cash equivalent Change -36.93 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 142
Healthcare Sector # 724
Overall Market # 2511


Quick Ratio Statistics
High Average Low
5.67 0.99 0.18
(Aug 31 2011)   (Feb 28 2014)




Financial Statements
Angiodynamics Inc 's Current Liabilities $ 60 Millions Visit ANGO's Balance sheet
Angiodynamics Inc 's Cash & cash equivalent $ 34 Millions Visit ANGO's Balance sheet
Source of ANGO's Sales Visit ANGO's Sales by Geography


Cumulative Angiodynamics Inc 's Quick Ratio

ANGO's Quick Ratio for the trailling 12 Months

ANGO Quick Ratio

(Aug 31 2026)
12 Months
(May 31 2026)
12 Months
(Feb 28 2026)
12 Months
(Nov 30 2025)
12 Months
(Aug 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth -12.41 %
Y / Y Cash & cash equivalent TTM Growth -13.55 %
Quick Ratio TTM 0.61
Total Ranking TTM # 4022
Seq. Current Liabilities TTM Growth -3.06 %
Seq. Cash & cash equivalent TTM Growth -2.78 %


On the trailing twelve months basis In spite of the year on year decrease in ANGO's Current Liabilities to $59.69 millions, cumulative Quick Ratio to 0.61 below the ANGO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Angiodynamics Inc . While Quick Ratio overall ranking has improved so far to 4022, from total ranking during the twelve months ending fourth quarter 2026 at 4030.

Explain Quick Ratio?
How much Cash & cash equivalents ANGO´s has?
What are ANGO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 205
Healthcare Sector # 901
Within the Market # 4022


trailing twelve months Quick Ratio Statistics
High Average Low
2.35 0.74 0.2
(Nov 30 2019)   (Nov 30 2014)




Companies with similar Quick Ratio in the quarter ending Aug 31 2026, within Medical Equipment & Supplies Industry Quick RatioAug 31 2026 MRQ Cash & cash equivalentAug 31 2026 MRQ Current Liabilities
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions
Globus Medical Inc   1.02 $ 517.435  Millions$ 507.938  Millions
Envoy Medical Inc   0.98 $ 14.570  Millions$ 14.861  Millions
Integra Lifesciences Holdings Corp  0.95 $ 311.930  Millions$ 329.002  Millions
Strata Critical Medical Inc   0.92 $ 41.641  Millions$ 45.118  Millions
Haemonetics Corporation  0.87 $ 260.712  Millions$ 300.838  Millions
Treace Medical Concepts Inc   0.86 $ 39.798  Millions$ 46.079  Millions
Innovage Holding Corp   0.85 $ 162.993  Millions$ 192.479  Millions
Lifestance Health Group Inc   0.84 $ 218.818  Millions$ 261.129  Millions
Neuronetics Inc   0.82 $ 22.106  Millions$ 26.856  Millions
Orthopediatrics Corp  0.80 $ 44.229  Millions$ 55.632  Millions
Livanova Plc  0.76 $ 563.467  Millions$ 740.193  Millions
West Pharmaceutical Services Inc   0.72 $ 464.100  Millions$ 644.300  Millions
Resmed Inc   0.72 $ 1,010.742  Millions$ 1,406.488  Millions
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions
Orthofix Medical Inc   0.62 $ 86.322  Millions$ 138.385  Millions
Carlisle Companies Incorporated  0.62 $ 546.700  Millions$ 880.300  Millions
Align Technology inc   0.57 $ 1,144.931  Millions$ 2,002.010  Millions
Angiodynamics Inc   0.57 $ 33.973  Millions$ 59.689  Millions
Baxter International Inc   0.52 $ 1,976.000  Millions$ 3,809.000  Millions

Date modified: 2026-10-09T04:24:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.